Page 71 - Read Online

Page 12 of 13 Eng et al. J Cancer Metastasis Treat 2019;5:69 I http://dx.doi.org/10.20517/2394-4722.2019.021

63. Wang WJ, Yang W, Ouyang ZH, Xue JB, Li XL, et al. MiR-21 promotes ECM degradation through inhibiting autophagy via the
PTEN/akt/mTOR signaling pathway in human degenerated NP cells. Biomed Pharmacother 2018;99:725-34.
64. Liu ZL, Wang H, Liu J, Wang ZX. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in
non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 2013;372:35-45.
65. Xu Y, Yang J, Li F, Lian G, Ouyang M. MiR-29a inhibited intestinal epithelial cells autophagy partly by decreasing ATG9A in
ulcerative colitis. Anti-Cancer Drug 2018;29:652-9.
66. Tang W, Zhu Y, Gao J, Fu J, Liu C, et al. MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase
2 and E-cadherin via KLF4. Br J Cancer 2013;110:450-8.
67. Li N, Miao Y, Shan Y, Liu B, Li Y, et al. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt
pathway in breast cancer. Cell Death Dis 2017;8:e2796.
68. Lu C, Chen J, Xu HG, Zhou X, He Q, et al. MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting
ATG16L1-mediated autophagy. Gastroenterology 2014;146:188-99.
69. Chu S, Liu G, Xia P, Chen G, Shi F, et al. miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer.
Oncol Rep 2017;38:2401-7.
70. Hu JL, He GY, Lan XL, Zeng ZC, Guan J, et al. Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in
colorectal cancer. Oncogenesis 2018;7:16.
71. Liu J, Li D, Dang L, Liang C, Guo B, et al. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast
cancer. Sci Rep 2017;7:40487.
72. Xu J, Su Y, Xu A, Fan F, Mu S, et al. miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple
Myeloma. Mol Ther 2019;27:559-70.
73. Liang YK, Lin HY, Dou XW, Chen M, Wei XL, et al. MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in
breast cancer cell lines. NPJ Breast Cancer 2018;4:20.
74. Dubinsky AN, Ghosh Dastidar S, Hsu CL, Zahra R, Djakovic S, et al. Let-7 coordinately suppresses components of the amino acid
sensing pathway to repress mTORC1 and induce autophagy. Cell Metab 2014;20:626-38 .
75. Ling R, Zhou Y, Zhou L, Dai D, Wu D, et al. Lin28/microRNA-let-7a promotes metastasis under circumstances of hyperactive Wnt
signaling in esophageal squamous cell carcinoma. Mol Med Rep 2018;17:5265-71.
76. Fang Y, Xue JL, Shen Q, Chen J, Tian L. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide
3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 2012;55:1852-62.
77. Kong X, Li G, Yuan Y, He Y, Wu X. MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Cells via Targeting FAK Expression. PLoS One 2012;7:e41523.
78. Janaki Ramaiah M, Lavanya A, Honarpisheh M, Zarea M, Bhadra U, et al. MiR-15/16 complex targets p70S6 kinase1 and controls cell
proliferation in MDA-MB-231 breast cancer cells. Gene 2014;552:255-64.
79. Zhang H, Yang K, Ren T, Huang Y, Tang X, et al. MiR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting
Smad3 article. Cell Death Dis 2018;9:680.
80. Pennati M, Lopergolo A, Profumo V, De Cesare M, Sbarra S, et al. miR-205 impairs the autophagic flux and enhances cisplatin
cytotoxicity in castration-resistant prostate cancer cells. Biochem Pharmacol 2014;87:579-97.
81. Zhuo Z, Yu H, Zhuo Z,Yu H, Zhuo Z, et al. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant
endometrial cancer Ishikawa cells. Oncotarget 2017;8:28042-51.
82. Gulei D, Magdo L, Jurj A, Raduly L, Cojocneanu-Petric R, et al. The silent healer: miR-205-5p up-regulation inhibits epithelial to
mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression. Cell Death Dis 2018;9:66.
83. Chen D, Sun Y, Yuan Y, Han Z, Zhang P, et al. miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis,
Migration and Invasion. PLoS Genet 2014;10:e1004177.
84. Wang C, Zhang W, Zhang L, Chen X, Liu F, et al. miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous
cell carcinoma via targeting Notch2. Brit J Cancer 2016;115:1548-54.
85. Zhang MX, Zhang J, Zhang H, Tang H. MiR-24-3p suppresses malignant behavior of lacrimal adenoid cystic carcinoma by targeting
PRKCH to regulate p53/p21 pathway. PLoS ONE 2016;11:e0158433.
86. Chao CC, Wu PH, Huang HC, Chung HY, Chou YC, et al. Downregulation of miR-199a/b-5p is associated with GCNT2 induction
upon epithelial-mesenchymal transition in colon cancer. FEBS Lett 2017;591:1902-17.
87. Bornachea O, Santos M, Martínez-Cruz AB, García-Escudero R, Dueñas M, et al. EMT and induction of miR-21 mediate metastasis
development in Trp53-deficient tumours. Sci Rep 2012;2:434.
88. Vera-Ramirez L, Vodnala SK, Nini R, Hunter KW, Green JE. Autophagy promotes the survival of dormant breast cancer cells and
metastatic tumour recurrence. Nat Commun 2018;9:1944.
89. DeVita VT Jr, Chu E. A history of cancer chemotherapy. Cancer Res 2008;68:8643-53.
90. Keklikoglou I, Cianciaruso C, Guc E, Squadrito ML, Spring LM, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in
breast cancer models. Nat Cell Biol 2019;21:190-202.
91. Schoenherr C, Byron A, Sandilands E, Paliashvili K, Baillie GS, et al. Ambra1 spatially regulates Src activity and Src/FAK-mediated
cancer cell invasion via trafficking networks. Elife 2017;6:e23172.
92. Sharifi MN, Mowers EE, Drake LE, Collier C, Chen H, et al. Autophagy Promotes Focal Adhesion Disassembly and Cell Motility of
Metastatic Tumor Cells through the Direct Interaction of Paxillin with LC3. Cell Rep 2016;15:1660-72.
93. Anderson RL, Balasas T, Callaghan J, Coombes RC, Evans J, et al. A framework for the development of effective anti-metastatic